Kenneth I Berns
Overview
Explore the profile of Kenneth I Berns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berns K, Byrne B, Flotte T, Samulski R, Srivastava A
Hum Gene Ther
. 2023 Feb;
34(3-4):81-82.
PMID: 36794979
No abstract available.
2.
Berns K, Byrne B, Flotte T, Samulski R, Srivastava A
Mol Ther
. 2023 Feb;
31(3):607.
PMID: 36764298
No abstract available.
3.
Berns K
Hum Gene Ther
. 2020 Feb;
31(9-10):518-523.
PMID: 32079423
Although the sequence of the AAV inverted terminal repeat has been known for 40 years, there are still unanswered questions about functions attributable to the terminal 125 nucleotides.
4.
Berns K, Srivastava A
Gastroenterol Clin North Am
. 2019 May;
48(2):319-330.
PMID: 31046978
Recombinant vectors based on a nonpathogenic parvovirus, the adeno-associated virus (AAV), have taken center stage in the past decade. The safety of AAV vectors in clinical trials and clinical efficacy...
5.
Berns K, Muzyczka N
Hum Gene Ther
. 2017 Mar;
28(4):308-313.
PMID: 28335618
AAV has been studied for 55 years and has been developed as a vector for about 35 years. By now, there is a fairly good idea of the dimensions of...
6.
Berns K, Byrne B, Flotte T, Gao G, Hauswirth W, Herzog R, et al.
Hum Gene Ther
. 2015 Dec;
26(12):779-81.
PMID: 26690810
No abstract available.
7.
8.
Chen R, Carbery B, Mac L, Berns K, Chapman L, Condit R, et al.
Vaccine
. 2014 Oct;
33(1):73-5.
PMID: 25305565
Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing novel vaccines against human pathogens from Ebola to tuberculosis. An...
9.
10.
Berns K
DNA Cell Biol
. 2013 Jun;
32(7):342-7.
PMID: 23781880
My 45 years of studying the molecular biology of adeno-associated virus are recounted. Additional activities as a mentor, department chair, and medical school administrator are described, as are my activities...